B. Turner and P. Hadley, Constituents of Cannabis sativa L. VI: Propyl Homologs in Samples of Known Geographical Origin, Cannabis market, dans World Drug Report 2012, pp.621739-1741, 1973.
DOI : 10.1002/jps.2600621045

C. Ben-lakhdar, P. Ofdt, and . Beck-françois, Le trafic du cannabis en France: estimations des gains des dealers afin d'apprécier le potentiel de blanchiment « Consommation et surconsommation de cannabis : apports et limites de l'épidémiologie », Psychotropes 1, Les niveaux d'usage des drogues en France en 2010 Cannabis, données essentielles, pp.9-31, 2007.

S. Spilka and E. Janssen, Détection des usages problématiques de cannabis: le cannabis abuse screenning test (CAST) Note n°2013-01, Saint-Denis, le 03, 2013.

L. B. Whan-ph, Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro, Fertility and Sterility, vol.85, issue.3, pp.653-660, 2006.
DOI : 10.1016/j.fertnstert.2005.08.027

A. Aversa and F. Rossi, Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users, International Journal of Impotence Research, vol.42, issue.6, pp.566-73, 2008.
DOI : 10.1002/j.1552-4604.2002.tb06004.x

J. Park, M. Mcpartland, and . Glass, Cannabis, cannabinoids and reproduction - Prostaglandins Leukot Essent Fatty Acids., fév, pp.189-197, 2004.

J. Bauman, Marijuana and the female reproductive system, in: Health Consequence of Marijuana Use, US Government printing office, Nature Medicine, issue.25, pp.85-97, 1980.

F. Chao and D. Green, The passage of 14C-delta-9-tetrahydrocannabinol into the milk of lactating squirrel monkeys, Res Commun Chem Pathol Pharmacol, pp.303-317, 1976.

B. Gorzalka and M. Hill, Male???female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function, Hormones and Behavior, vol.58, issue.1, pp.91-100, 2010.
DOI : 10.1016/j.yhbeh.2009.08.009

J. Costentin, Neurobiologie du cannabis

B. Zalc, Institut du cerveau et de la moelle épinière (Paris), La sclérose en plaque (SEP) -Octobre 2014, article disponible sur le site internet : http://www.inserm.fr/thematiques/neurosciences-sciences- cognitives-neurologie-psychiatrie/dossiers-d-information/sclerose-en-plaques-sep

A. Salazar, Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells, Journal of Clinical Investigation, vol.119, issue.5, pp.1359-1372, 2009.
DOI : 10.1172/JCI37948DS1

). J. Marcu and R. T. Christian, Cannabidiol enhances the inhibitory effects of ?9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival, pp.180-189, 2010.

R. Ramer and B. Hin, Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1, JNCI: Journal of the National Cancer Institute, vol.144, issue.1, pp.59-69, 2007.
DOI : 10.1038/sj.bjp.0706134

M. Mimeault and N. Pommery, Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down-regulation and ceramide production, The Prostate, vol.12, issue.1, pp.1-12, 2003.
DOI : 10.1007/BF00184107

P. Nagarkatti and R. Pandey, Cannabinoids as novel anti-inflammatory drugs, Future Medicinal Chemistry, vol.115, issue.7, pp.1333-1349, 2009.
DOI : 10.1016/j.neulet.2004.06.060

URL : http://europepmc.org/articles/pmc2828614?pdf=render

. Waller, Dissiper la fumée entourant le cannabis Usage de cannabis et de cannabinoïdes à des fins médicales, 2014.

T. Gamage and A. Lichtman, The endocannabinoid system: role in energy regulation, 2012, Pediatr Blood Cancer

L. Strat, Y. , L. Foll, and B. , Obesity and Cannabis Use: Results From 2 Representative National Surveys, American Journal of Epidemiology, vol.15, issue.1, pp.929-962, 2011.
DOI : 10.1038/oby.2007.536

). Elikottil, P. Gupta, and K. Gupta, The analgesic potential of cannabinoids, Journal of Opioid Management, vol.5, issue.6, pp.341-357, 2009.
DOI : 10.5055/jom.2009.0034

D. Centonze and F. Mori, Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis, Neurological Sciences, vol.404, issue.6, pp.531-534, 2009.
DOI : 10.1111/j.1468-1331.2006.01639.x

R. Freeman and O. Adekanmi, The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS), International Urogynecology Journal, vol.155, issue.3, pp.636-677, 2006.
DOI : 10.1111/j.1476-5381.1996.tb15643.x

C. Dr, C. Vaneyn-médecin-chef-neurologie, and . Bernoise, Crans-Montana, Cannabis et sclérose en plaque, 26.03 Le fait médical, article disponible sur http, 2009.

M. Rocha and R. Olivera, Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. septembre, Eur J Cancer Care, pp.431-431365, 2008.

. Noyes, The analgesic properties of delta-9-tetrahydrocannabinol and codeine, Clinical Pharmacology & Therapeutics, vol.18, issue.1, pp.84-89, 1975.
DOI : 10.1002/cpt197518184

J. Roberts, C. Gennings, and M. Shih, Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine, European Journal of Pharmacology, vol.530, issue.1-2, pp.54-62, 2006.
DOI : 10.1016/j.ejphar.2005.11.036

. Dr-franjo-grotenhermen, Cannabis en médecine, un guide pratique des application médicale du cannabis et du THC, pp.87-89, 2004.

P. Beaulieu and M. Ware, Reassessment of the role of cannabinoids in the management of pain and other symptoms, Curr Opin Anaesthesiol, pp.473-480, 2007.

A. Holdcroft and M. Maze, A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management, Anesthesiology, vol.104, issue.5, pp.1040-1046, 2006.
DOI : 10.1097/00000542-200605000-00021

M. Ware, Smoked cannabis for chronic neuropathic pain: a randomized controlled trial, Canadian Medical Association Journal, vol.182, issue.14, 2010.
DOI : 10.1503/cmaj.091414

N. Bowery, O. Hill, and A. Hudson, (???)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor, Nature, vol.52, issue.5742, pp.92-94, 1980.
DOI : 10.1113/jphysiol.1961.sp006646

. Académie-de-médecine, Communiqué de presse : SATIVEX, un suivi rigoureux en matière de pharmacovigilance et d'addictovigilance s'impose

K. Schoedel and N. Chen, A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use, Human Psychopharmacology: Clinical and Experimental, vol.94, issue.64
DOI : 10.1016/j.drugalcdep.2007.11.017

M. Saed-abdul-rahman and I. , Questions and Answers -Pedagogy Education and Upbringing Yoreh De'ah section III, Rav Moshé Feinstein, Iggerot Moshevol, vol.6, issue.73, pp.123-978, 2003.

D. Pharmacie and . Par, Munch Gui llaume Sujet : Le cannabis, les deux versants : drogue et médicament